Levetiracetam 1 A Pharma

Levetiracetam, the active ingredient in Levetiracetam 1 A Pharma, is an anticonvulsant presented as an oral dosage form for oral use. It is used to treat partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an anticonvulsant indicated for several seizure types.

Partial‑onset seizures: reduces the frequency of focal seizures. Generalized tonic‑clonic seizures: helps control convulsive episodes. Myoclonic seizures: decreases the occurrence of myoclonic jerks.

Levetiracetam is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness - Somnolence or fatigue - Headache - Irritability or mood changes - Nausea or gastrointestinal discomfort - Coordination difficulties

Serious or Rare Side Effects: - Severe allergic reactions such as Stevens‑Johnson syndrome - Rash or skin eruptions - Suicidal thoughts or behavior - Significant mood or psychiatric disturbances - Blood dyscrasias including leukopenia or thrombocytopenia - Rare cases of hepatic dysfunction

Before initiating therapy, clinicians should consider several safety measures.

Assess renal function: adjust dose in patients with impaired clearance. Monitor mood: watch for depression, anxiety, or behavioral changes. Avoid abrupt discontinuation: taper under medical supervision to prevent seizure worsening. Use caution in pregnancy: limited data require a risk‑benefit assessment. Inform patients about drowsiness: advise against operating machinery until individual response is known. Store at ambient temperature: keep in the original pack, protect from moisture.

Levetiracetam may interact with other medicines, requiring attention to co‑administration.

Major Interactions (Avoid): - Co‑administration with strong enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin) may markedly reduce levetiracetam plasma concentrations. - Concurrent use with other central nervous system depressants can lead to excessive sedation or respiratory depression.

Moderate Interactions (Monitor Closely): - Combination with other antiepileptic drugs may require dose adjustments based on therapeutic response. - Use with alcohol may enhance drowsiness and impair coordination. - Certain immunosuppressants (e.g., tacrolimus) may have altered levels; monitor plasma concentrations when used together.